BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 06, 2010
 |  BC Week In Review  |  Company News  |  Deals

Clinical Data, Transgenomic deal

Transgenomic will acquire Clinical Data's genetic and pharmacogenomic testing and biomarker development business for approximately $15.4 million. The deal includes $6 million in cash, a three-year promissory note for $8.5 million that bears 10% interest and a one-year promissory note for $932,000 that bears 6.5% interest. Clinical Data will receive a percentage of...

Read the full 244 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >